According to the 2016 Top Markets Report Pharmaceuticals issued by International Trade Administration, U.S. Department of Commerce, “the pharmaceutical market in China is one of the most promising for U.S. exportsin the long-term given its size and growth potential”.
China is the second largest pharmaceutical market in the world, forecasted to consume $167 billion by 2020 with an annual growth rate of 9.1%. Its total public and private healthcare expenditure reached 640 billion in 2015 and is expected to double to 1.1 trillion by 2020.
In 2015, U.S. pharmaceutical exports to China reached $2 billion. Comparing to the $617 million volume in 2010, the annual growth rate was 26.6% in five years. The U.S. is a leading source of pharmaceutical imports to China, taking up 11% of China’s import market share.
Copyright © 2023 Kang Lida New York Inc. - All Rights Reserved.